Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroendocrine Tumors 4von Hippel-Lindau Disease 2Prostatic Neoplasms 2Meningioma 2Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Paraganglioma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Multiple Endocrine Neoplasia 1Medulloblastoma 1Hypoglycemia 1Hypertension 1Hyperparathyroidism 1Hypercalcemia 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

Hydroxyurea 7Bevacizumab 7Everolimus 6lutetium Lu 177 dotatate 4Magnetic Resonance Spectroscopy 4pembrolizumab 3abemaciclib 3Sunitinib 3Imatinib Mesylate 3vistusertib 2gallium Ga 68 dotatate 2arginyllysine 2aldesleukin 2Whole Body Imaging 2Specimen Handling 2Radiotherapy 2Octreotide 2Nivolumab 2Cyclophosphamide 2Amino Acids 290Y-octreotide, DOTA-Tyr(3)- 2vatalanib 1tozuleristide 1sargramostim 1regorafenib 1pasireotide 1neratinib 1fludarabine phosphate 1fludarabine 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Meningioma × gallium Ga 68 dotatate × Clear all
NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Mayo Clinic

Phase 2 Recruiting
42 enrolled
CNS

Meningioma

NCT04298541 2026-02-27

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Weill Medical College of Cornell University

Phase 2 Not yet recruiting
6 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡